APO Research
Talk to an analyst

APO RESEARCH · REPORT

Specialty Drug Distribution

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.

It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.

Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.

Selected research

Market Analysis & Forecast

Global Specialty Drug Distribution Market Analysis and Forecast 2026-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchSpecialty Drug Distribution Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Specialty Drug Distribution Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Specialty Drug Distribution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Specialty Drug Distribution Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Specialty Drug Distribution Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.

It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.

Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.

Read the full market overview

Global Specialty Drug Distribution key players include Amerisource, Mckesson, Cardinal Health, PHOENIX group, etc.

North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.

In terms of product, Oncology is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital and Clinics, followed by Pharmacy, etc.

Report Includes

This report presents an overview of global market for Specialty Drug Distribution, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Specialty Drug Distribution, also provides the revenue of main regions and countries. Of the upcoming market potential for Specialty Drug Distribution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Specialty Drug Distribution revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Specialty Drug Distribution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Specialty Drug Distribution revenue, projected growth trends, production technology, application and end-user industry.

Specialty Drug Distribution Segment by Company

AmerisourceBergen

Mckesson

Cardinal Health

Phoenix

Medipal Holdings

Alliance Healthcare

Sinopharm

Express Scripts

Shanghai Pharma

Anda

Jointown

Max Pharma

Specialty Drug Distribution Segment by Type

Oncology

Rheumatoid Arthritis

Multiple Sclerosis

Hemophilia

Others

Specialty Drug Distribution Segment by Application

Hospital and Clinic

Pharmacy

Others

Specialty Drug Distribution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Specialty Drug Distribution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Specialty Drug Distribution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Specialty Drug Distribution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Specialty Drug Distribution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Specialty Drug Distribution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Specialty Drug Distribution revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Specialty Drug Distribution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oncology Major Player Table 3. Rheumatoid Arthritis Major Player Table 4. Multiple Sclerosis Major Player Table 5. Hemophilia Major Player Table 6. Others Major Player Table 7. Global Specialty Drug Distribution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital and Clinic Major Player Table 9. Pharmacy Major Player Table 10. Others Major Player Table 11. Specialty Drug Distribution Industry Trends Table 12. Specialty Drug Distribution Industry Drivers Table 13. Specialty Drug Distribution Industry Opportunities and Challenges Table 14. Specialty Drug Distribution Industry Restraints Table 15. Global Specialty Drug Distribution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Specialty Drug Distribution Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Specialty Drug Distribution Market Share by Region (2021-2026) Table 18. Global Specialty Drug Distribution Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Specialty Drug Distribution Market Share by Region (2027-2032) Table 20. Global Specialty Drug Distribution Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Specialty Drug Distribution Revenue Market Share by Players (2021-2026) Table 22. Global Specialty Drug Distribution Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Specialty Drug Distribution Key Players Headquarters & Area Served Table 24. Global Specialty Drug Distribution Players, Product Type & Application Table 25. Global Specialty Drug Distribution Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Specialty Drug Distribution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Specialty Drug Distribution Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Specialty Drug Distribution Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Specialty Drug Distribution Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Specialty Drug Distribution Revenue Market Share by Type (2021-2026) Table 32. Global Specialty Drug Distribution Revenue Market Share by Type (2027-2032) Table 33. Global Specialty Drug Distribution Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Specialty Drug Distribution Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Specialty Drug Distribution Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Specialty Drug Distribution Revenue Market Share by Application (2021-2026) Table 37. Global Specialty Drug Distribution Revenue Market Share by Application (2027-2032) Table 38. AmerisourceBergen Company Information Table 39. AmerisourceBergen Business Overview Table 40. AmerisourceBergen Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. AmerisourceBergen Specialty Drug Distribution Product Portfolio Table 42. AmerisourceBergen Recent Development Table 43. Mckesson Company Information Table 44. Mckesson Business Overview Table 45. Mckesson Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Mckesson Specialty Drug Distribution Product Portfolio Table 47. Mckesson Recent Development Table 48. Cardinal Health Company Information Table 49. Cardinal Health Business Overview Table 50. Cardinal Health Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Cardinal Health Specialty Drug Distribution Product Portfolio Table 52. Cardinal Health Recent Development Table 53. Phoenix Company Information Table 54. Phoenix Business Overview Table 55. Phoenix Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Phoenix Specialty Drug Distribution Product Portfolio Table 57. Phoenix Recent Development Table 58. Medipal Holdings Company Information Table 59. Medipal Holdings Business Overview Table 60. Medipal Holdings Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Medipal Holdings Specialty Drug Distribution Product Portfolio Table 62. Medipal Holdings Recent Development Table 63. Alliance Healthcare Company Information Table 64. Alliance Healthcare Business Overview Table 65. Alliance Healthcare Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Alliance Healthcare Specialty Drug Distribution Product Portfolio Table 67. Alliance Healthcare Recent Development Table 68. Sinopharm Company Information Table 69. Sinopharm Business Overview Table 70. Sinopharm Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Sinopharm Specialty Drug Distribution Product Portfolio Table 72. Sinopharm Recent Development Table 73. Express Scripts Company Information Table 74. Express Scripts Business Overview Table 75. Express Scripts Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Express Scripts Specialty Drug Distribution Product Portfolio Table 77. Express Scripts Recent Development Table 78. Shanghai Pharma Company Information Table 79. Shanghai Pharma Business Overview Table 80. Shanghai Pharma Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Shanghai Pharma Specialty Drug Distribution Product Portfolio Table 82. Shanghai Pharma Recent Development Table 83. Anda Company Information Table 84. Anda Business Overview Table 85. Anda Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Anda Specialty Drug Distribution Product Portfolio Table 87. Anda Recent Development Table 88. Jointown Company Information Table 89. Jointown Business Overview Table 90. Jointown Specialty Drug Distribution Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Jointown Specialty Drug Distribution Product Portfolio Table 92. Jointown Recent Development Table 93. Max Pharma Company Information Table 94. Max Pharma Business Overview Table 95. Max Pharma Specialty Drug Distribution Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Max Pharma Specialty Drug Distribution Product Portfolio Table 97. Max Pharma Recent Development Table 98. North America Specialty Drug Distribution Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Specialty Drug Distribution Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Specialty Drug Distribution Revenue by Application (2021-2026) & (US$ Million) Table 101. North America Specialty Drug Distribution Revenue by Application (2027-2032) & (US$ Million) Table 102. North America Specialty Drug Distribution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America Specialty Drug Distribution Revenue by Country (2021-2026) & (US$ Million) Table 104. North America Specialty Drug Distribution Revenue by Country (US$ Million) & (2027-2032) Table 105. Europe Specialty Drug Distribution Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Specialty Drug Distribution Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Specialty Drug Distribution Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe Specialty Drug Distribution Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe Specialty Drug Distribution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe Specialty Drug Distribution Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Specialty Drug Distribution Revenue by Country (US$ Million) & (2027-2032) Table 112. China Specialty Drug Distribution Revenue by Type (2021-2026) & (US$ Million) Table 113. China Specialty Drug Distribution Revenue by Type (2027-2032) & (US$ Million) Table 114. China Specialty Drug Distribution Revenue by Application (2021-2026) & (US$ Million) Table 115. China Specialty Drug Distribution Revenue by Application (2027-2032) & (US$ Million) Table 116. Asia Specialty Drug Distribution Revenue by Type (2021-2026) & (US$ Million) Table 117. Asia Specialty Drug Distribution Revenue by Type (2027-2032) & (US$ Million) Table 118. Asia Specialty Drug Distribution Revenue by Application (2021-2026) & (US$ Million) Table 119. Asia Specialty Drug Distribution Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia Specialty Drug Distribution Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Asia Specialty Drug Distribution Revenue by Region (US$ Million) & (2021-2026) Table 122. Asia Specialty Drug Distribution Revenue by Region (US$ Million) & (2027-2032) Table 123. SAMEA Specialty Drug Distribution Revenue by Type (2021-2026) & (US$ Million) Table 124. SAMEA Specialty Drug Distribution Revenue by Type (2027-2032) & (US$ Million) Table 125. SAMEA Specialty Drug Distribution Revenue by Application (2021-2026) & (US$ Million) Table 126. SAMEA Specialty Drug Distribution Revenue by Application (2027-2032) & (US$ Million) Table 127. SAMEA Specialty Drug Distribution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. SAMEA Specialty Drug Distribution Revenue by Country (2021-2026) & (US$ Million) Table 129. SAMEA Specialty Drug Distribution Revenue by Country (US$ Million) & (2027-2032) Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Specialty Drug Distribution Image Figure 2. Global Specialty Drug Distribution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Specialty Drug Distribution Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oncology Image Figure 5. Rheumatoid Arthritis Image Figure 6. Multiple Sclerosis Image Figure 7. Hemophilia Image Figure 8. Others Image Figure 9. Global Specialty Drug Distribution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Specialty Drug Distribution Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital and Clinic Image Figure 12. Pharmacy Image Figure 13. Others Image Figure 14. Global Specialty Drug Distribution Market Size (US$ Million) & (2021-2032) Figure 15. Global Specialty Drug Distribution Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Specialty Drug Distribution Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Specialty Drug Distribution Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Specialty Drug Distribution Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Specialty Drug Distribution Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Specialty Drug Distribution Revenue Market Share by Type (2021-2032) Figure 22. Global Specialty Drug Distribution Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Specialty Drug Distribution Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Specialty Drug Distribution Revenue Market Share by Application (2021-2032) Figure 25. North America Specialty Drug Distribution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Specialty Drug Distribution Revenue Share by Type (2021-2032) Figure 27. North America Specialty Drug Distribution Revenue Share by Application (2021-2032) Figure 28. North America Specialty Drug Distribution Revenue Share by Country (2021-2032) Figure 29. United States Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Specialty Drug Distribution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Specialty Drug Distribution Revenue Share by Type (2021-2032) Figure 34. Europe Specialty Drug Distribution Revenue Share by Application (2021-2032) Figure 35. Europe Specialty Drug Distribution Revenue Share by Country (2021-2032) Figure 36. Germany Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Specialty Drug Distribution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Specialty Drug Distribution Revenue Share by Type (2021-2032) Figure 46. China Specialty Drug Distribution Revenue Share by Application (2021-2032) Figure 47. Asia Specialty Drug Distribution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Specialty Drug Distribution Revenue Share by Type (2021-2032) Figure 49. Asia Specialty Drug Distribution Revenue Share by Application (2021-2032) Figure 50. Asia Specialty Drug Distribution Revenue Share by Region (2021-2032) Figure 51. Japan Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Specialty Drug Distribution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Specialty Drug Distribution Revenue Share by Type (2021-2032) Figure 59. SAMEA Specialty Drug Distribution Revenue Share by Application (2021-2032) Figure 60. SAMEA Specialty Drug Distribution Revenue Share by Country (2021-2032) Figure 61. Brazil Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Specialty Drug Distribution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oncology
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Hemophilia
  • Others
Applications
  • Hospital and Clinic
  • Pharmacy
  • Others
Companies covered
  • AmerisourceBergen
  • Mckesson
  • Cardinal Health
  • Phoenix
  • Medipal Holdings
  • Alliance Healthcare
  • Sinopharm
  • Express Scripts
  • Shanghai Pharma
  • Anda
  • Jointown
  • Max Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Specialty Drug Distribution Market by Type
  3. 1.2.1 Global Specialty Drug Distribution Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oncology
  5. 1.2.3 Rheumatoid Arthritis
  6. 1.2.4 Multiple Sclerosis
  7. 1.2.5 Hemophilia
  8. 1.2.6 Others
  9. 1.3 Specialty Drug Distribution Market by Application
  10. 1.3.1 Global Specialty Drug Distribution Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital and Clinic
  12. 1.3.3 Pharmacy
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Specialty Drug Distribution Market Dynamics
  1. 2.1 Specialty Drug Distribution Industry Trends
  2. 2.2 Specialty Drug Distribution Industry Drivers
  3. 2.3 Specialty Drug Distribution Industry Opportunities and Challenges
  4. 2.4 Specialty Drug Distribution Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Specialty Drug Distribution Market Perspective (2021-2032)
  2. 3.2 Global Specialty Drug Distribution Growth Trends by Region
  3. 3.2.1 Global Specialty Drug Distribution Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Specialty Drug Distribution Market Size by Region (2021-2026)
  5. 3.2.3 Global Specialty Drug Distribution Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Specialty Drug Distribution Revenue by Players
  2. 4.1.1 Global Specialty Drug Distribution Revenue by Players (2021-2026)
  3. 4.1.2 Global Specialty Drug Distribution Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Specialty Drug Distribution Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Specialty Drug Distribution Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Specialty Drug Distribution Key Players Headquarters & Area Served
  7. 4.4 Global Specialty Drug Distribution Players, Product Type & Application
  8. 4.5 Global Specialty Drug Distribution Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Specialty Drug Distribution Market CR5 and HHI
  11. 4.6.3 2025 Specialty Drug Distribution Tier 1, Tier 2, and Tier 3
5 Specialty Drug Distribution Market Size by Type
  1. 5.1 Global Specialty Drug Distribution Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Specialty Drug Distribution Revenue by Type (2021-2032)
  3. 5.3 Global Specialty Drug Distribution Revenue Market Share by Type (2021-2032)
6 Specialty Drug Distribution Market Size by Application
  1. 6.1 Global Specialty Drug Distribution Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Specialty Drug Distribution Revenue by Application (2021-2032)
  3. 6.3 Global Specialty Drug Distribution Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AmerisourceBergen
  2. 7.1.1 AmerisourceBergen Company Information
  3. 7.1.2 AmerisourceBergen Business Overview
  4. 7.1.3 AmerisourceBergen Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AmerisourceBergen Specialty Drug Distribution Product Portfolio
  6. 7.1.5 AmerisourceBergen Recent Developments
  7. 7.2 Mckesson
  8. 7.2.1 Mckesson Company Information
  9. 7.2.2 Mckesson Business Overview
  10. 7.2.3 Mckesson Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Mckesson Specialty Drug Distribution Product Portfolio
  12. 7.2.5 Mckesson Recent Developments
  13. 7.3 Cardinal Health
  14. 7.3.1 Cardinal Health Company Information
  15. 7.3.2 Cardinal Health Business Overview
  16. 7.3.3 Cardinal Health Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cardinal Health Specialty Drug Distribution Product Portfolio
  18. 7.3.5 Cardinal Health Recent Developments
  19. 7.4 Phoenix
  20. 7.4.1 Phoenix Company Information
  21. 7.4.2 Phoenix Business Overview
  22. 7.4.3 Phoenix Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Phoenix Specialty Drug Distribution Product Portfolio
  24. 7.4.5 Phoenix Recent Developments
  25. 7.5 Medipal Holdings
  26. 7.5.1 Medipal Holdings Company Information
  27. 7.5.2 Medipal Holdings Business Overview
  28. 7.5.3 Medipal Holdings Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Medipal Holdings Specialty Drug Distribution Product Portfolio
  30. 7.5.5 Medipal Holdings Recent Developments
  31. 7.6 Alliance Healthcare
  32. 7.6.1 Alliance Healthcare Company Information
  33. 7.6.2 Alliance Healthcare Business Overview
  34. 7.6.3 Alliance Healthcare Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Alliance Healthcare Specialty Drug Distribution Product Portfolio
  36. 7.6.5 Alliance Healthcare Recent Developments
  37. 7.7 Sinopharm
  38. 7.7.1 Sinopharm Company Information
  39. 7.7.2 Sinopharm Business Overview
  40. 7.7.3 Sinopharm Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sinopharm Specialty Drug Distribution Product Portfolio
  42. 7.7.5 Sinopharm Recent Developments
  43. 7.8 Express Scripts
  44. 7.8.1 Express Scripts Company Information
  45. 7.8.2 Express Scripts Business Overview
  46. 7.8.3 Express Scripts Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Express Scripts Specialty Drug Distribution Product Portfolio
  48. 7.8.5 Express Scripts Recent Developments
  49. 7.9 Shanghai Pharma
  50. 7.9.1 Shanghai Pharma Company Information
  51. 7.9.2 Shanghai Pharma Business Overview
  52. 7.9.3 Shanghai Pharma Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Shanghai Pharma Specialty Drug Distribution Product Portfolio
  54. 7.9.5 Shanghai Pharma Recent Developments
  55. 7.10 Anda
  56. 7.10.1 Anda Company Information
  57. 7.10.2 Anda Business Overview
  58. 7.10.3 Anda Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Anda Specialty Drug Distribution Product Portfolio
  60. 7.10.5 Anda Recent Developments
  61. 7.11 Jointown
  62. 7.11.1 Jointown Company Information
  63. 7.11.2 Jointown Business Overview
  64. 7.11.3 Jointown Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Jointown Specialty Drug Distribution Product Portfolio
  66. 7.11.5 Jointown Recent Developments
  67. 7.12 Max Pharma
  68. 7.12.1 Max Pharma Company Information
  69. 7.12.2 Max Pharma Business Overview
  70. 7.12.3 Max Pharma Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Max Pharma Specialty Drug Distribution Product Portfolio
  72. 7.12.5 Max Pharma Recent Developments
8 North America
  1. 8.1 North America Specialty Drug Distribution Revenue (2021-2032)
  2. 8.2 North America Specialty Drug Distribution Revenue by Type (2021-2032)
  3. 8.2.1 North America Specialty Drug Distribution Revenue by Type (2021-2026)
  4. 8.2.2 North America Specialty Drug Distribution Revenue by Type (2027-2032)
  5. 8.3 North America Specialty Drug Distribution Revenue Share by Type (2021-2032)
  6. 8.4 North America Specialty Drug Distribution Revenue by Application (2021-2032)
  7. 8.4.1 North America Specialty Drug Distribution Revenue by Application (2021-2026)
  8. 8.4.2 North America Specialty Drug Distribution Revenue by Application (2027-2032)
  9. 8.5 North America Specialty Drug Distribution Revenue Share by Application (2021-2032)
  10. 8.6 North America Specialty Drug Distribution Revenue by Country
  11. 8.6.1 North America Specialty Drug Distribution Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Specialty Drug Distribution Revenue by Country (2021-2026)
  13. 8.6.3 North America Specialty Drug Distribution Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Specialty Drug Distribution Revenue (2021-2032)
  2. 9.2 Europe Specialty Drug Distribution Revenue by Type (2021-2032)
  3. 9.2.1 Europe Specialty Drug Distribution Revenue by Type (2021-2026)
  4. 9.2.2 Europe Specialty Drug Distribution Revenue by Type (2027-2032)
  5. 9.3 Europe Specialty Drug Distribution Revenue Share by Type (2021-2032)
  6. 9.4 Europe Specialty Drug Distribution Revenue by Application (2021-2032)
  7. 9.4.1 Europe Specialty Drug Distribution Revenue by Application (2021-2026)
  8. 9.4.2 Europe Specialty Drug Distribution Revenue by Application (2027-2032)
  9. 9.5 Europe Specialty Drug Distribution Revenue Share by Application (2021-2032)
  10. 9.6 Europe Specialty Drug Distribution Revenue by Country
  11. 9.6.1 Europe Specialty Drug Distribution Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Specialty Drug Distribution Revenue by Country (2021-2026)
  13. 9.6.3 Europe Specialty Drug Distribution Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Specialty Drug Distribution Revenue (2021-2032)
  2. 10.2 China Specialty Drug Distribution Revenue by Type (2021-2032)
  3. 10.2.1 China Specialty Drug Distribution Revenue by Type (2021-2026)
  4. 10.2.2 China Specialty Drug Distribution Revenue by Type (2027-2032)
  5. 10.3 China Specialty Drug Distribution Revenue Share by Type (2021-2032)
  6. 10.4 China Specialty Drug Distribution Revenue by Application (2021-2032)
  7. 10.4.1 China Specialty Drug Distribution Revenue by Application (2021-2026)
  8. 10.4.2 China Specialty Drug Distribution Revenue by Application (2027-2032)
  9. 10.5 China Specialty Drug Distribution Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Specialty Drug Distribution Revenue (2021-2032)
  2. 11.2 Asia Specialty Drug Distribution Revenue by Type (2021-2032)
  3. 11.2.1 Asia Specialty Drug Distribution Revenue by Type (2021-2026)
  4. 11.2.2 Asia Specialty Drug Distribution Revenue by Type (2027-2032)
  5. 11.3 Asia Specialty Drug Distribution Revenue Share by Type (2021-2032)
  6. 11.4 Asia Specialty Drug Distribution Revenue by Application (2021-2032)
  7. 11.4.1 Asia Specialty Drug Distribution Revenue by Application (2021-2026)
  8. 11.4.2 Asia Specialty Drug Distribution Revenue by Application (2027-2032)
  9. 11.5 Asia Specialty Drug Distribution Revenue Share by Application (2021-2032)
  10. 11.6 Asia Specialty Drug Distribution Revenue by Country
  11. 11.6.1 Asia Specialty Drug Distribution Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Specialty Drug Distribution Revenue by Country (2021-2026)
  13. 11.6.3 Asia Specialty Drug Distribution Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Specialty Drug Distribution Revenue (2021-2032)
  2. 12.2 SAMEA Specialty Drug Distribution Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Specialty Drug Distribution Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Specialty Drug Distribution Revenue by Type (2027-2032)
  5. 12.3 SAMEA Specialty Drug Distribution Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Specialty Drug Distribution Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Specialty Drug Distribution Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Specialty Drug Distribution Revenue by Application (2027-2032)
  9. 12.5 SAMEA Specialty Drug Distribution Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Specialty Drug Distribution Revenue by Country
  11. 12.6.1 SAMEA Specialty Drug Distribution Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Specialty Drug Distribution Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Specialty Drug Distribution Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst